RNAZ CIK: 1829635

Transcode Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−5.27
FY22:
−15.8
FY23:
−18.1
FY24:
−13.3
FY25:
−19.5
Change from FY21 to FY25
millions USD
FY21:
−0.25
FY22:
−0.10
FY23:
−0.04
FY24:
−0.02
FY25:
0.00
Change from FY21 to FY25
millions USD
FY21:
25.5
FY22:
0.01
FY23:
15.9
FY24:
16.4
FY25:
31.5
millions USD
FY21:
20.0
FY22:
−15.9
FY23:
−2.20
FY24:
3.04
FY25:
12.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−5.52
FY22:
−15.9
FY23:
−18.1
FY24:
−13.4
FY25:
−19.5

All amounts in millions USD Data source:SEC EDGAR